An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

NCT02910739 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Amnestic Mild Cognitive Impairment
Alzheimer's Disease
Prodromal Alzheimer's Disease

Interventions

DRUG: MK-8931

Sponsor

Merck Sharp & Dohme LLC